About this trial
This randomized clinical trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
Eligibility criteria
Qualifiers
Voluntary informed consent to participate and capacity to consent; Age 18 to 65;
Diagnosis of schizophrenia, schizoaffective, bipolar I disorder or major depression with history of psychosis based on a diagnostic interview and available medical record review;
Minimum level of social avoidance defined by a score of ≥ 2 on the Scale for the Assessment of Negative Symptoms (SANS) asociality item;
Be willing and able to speak English at ≥ 6th grade reading level (to read intervention workbook).
Disqualifiers
Prior cognitive-behavioral therapy in the past 2 years;
Greater than moderate disorganization on the PANSS (P2- Disorganization item >5);
Alcohol or substance dependence in past 3 months based on the diagnostic interview;
Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness);
Trial design
Treatments tested in this trial
- Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE)
- Supportive Contact (SC)
Treatment groups
Sponsors and collaborators
University of California, San Diego
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator